Cargando…
Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity
The transcription factor PLZF (promyelocytic leukemia zinc finger protein) acts as an epigenetic regulator balancing self-renewal and differentiation of hematopoietic cells through binding to various chromatin-modifying factors. First described as a transcriptional repressor, PLZF is also associated...
Autores principales: | Koubi, Myriam, Poplineau, Mathilde, Vernerey, Julien, N’Guyen, Lia, Tiberi, Guillaume, Garciaz, Sylvain, El-Kaoutari, Abdessamad, Maqbool, Muhammad A, Andrau, Jean-Christophe, Guillouf, Christel, Saurin, Andrew J, Duprez, Estelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909434/ https://www.ncbi.nlm.nih.gov/pubmed/29425303 http://dx.doi.org/10.1093/nar/gky080 |
Ejemplares similares
-
PLZF limits enhancer activity during hematopoietic progenitor aging
por: Poplineau, Mathilde, et al.
Publicado: (2019) -
HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia
por: Gregoricchio, Sebastian, et al.
Publicado: (2022) -
Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias
por: Poplineau, Mathilde, et al.
Publicado: (2022) -
Characterisation of Genome-Wide PLZF/RARA Target Genes
por: Spicuglia, Salvatore, et al.
Publicado: (2011) -
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
por: Garciaz, Sylvain, et al.
Publicado: (2019)